Stephanie Marchesseau1, Sue-Ann P.L Ng2, Andrea H.L. Low2,3, YT Wang4, Jamie X.M Ho1, Josh D. Schaefferkoetter1, and John J. Totman1
1Clinical Imaging Research Centre, NUS, Singapore, Singapore, 2Departement of Rheumatology and Immunology, SGH, Singapore, Singapore, 3Duke-National University, Singapore, Singapore, 4Department of Gastroenterology and Hepatology, SGH, Singapore, Singapore
Synopsis
Systemic sclerosis (SSc) is a multi-system disease
characterized by immune dysregulation, fibrosis and vascular damage that affects
the gastrointestinal tract in most patients. In this study,
we investigate simultaneous FDG-PET/MR imaging for the diagnosis of SSc GIT involvement. Our preliminary results show that FDG-PET can detect inflammation in the bowels while T1 MOLLI mapping could be able to distinguish
healthy from fibrotic GIT tissue.BACKGROUND
Systemic sclerosis (SSc) is a multi-system disease
characterized by immune dysregulation, fibrosis and vascular damage that affects
the gastrointestinal tract (GIT) in up to 90% of patients. Baseline GIT
involvement is an independent predictor of 2-year mortality in patients with
early diffuse SSc. An urgent unmet need in the management of SSc GIT
involvement is the availability of non-invasive investigations to facilitate
early diagnosis, monitoring of disease and treatment response. In this study,
we investigate simultaneous FDG-PET/MR imaging for the diagnosis of SSc GIT involvement,
hypothesizing that (i) FDG-PET detects inflammation in the bowels associated
with early involvement of the GI tract, and (ii) T1 MOLLI mapping is able to distinguish
healthy from fibrotic GIT tissue as already demonstrated on cardiac tissue [2].The
authors are unaware of any other studies assessing the GI involvement in SSc using
FDG-PET or T1 MOLLI maps to investigate bowel fibrosis.
METHODS
Image Acquisition:
n this institutional review board approved pilot study, 2 SSc
patients with symptomatic GIT symptoms, as determined by a validated questionnaire
were recruited (female, aged 24 and 62). Subjects fasted for at least 10
hours prior and had a non-spicy low residue diet 3 days prior. Subjects underwent a PET-MR scan (Siemens
mMR), 60 minutes after injection of 6mCi of FDG tracer and immediately after
injection of 10ml of Buscopan to reduce bowel motion. PET images were acquired
on four 10 minute beds to cover the abdomen and thorax. PET data were
reconstructed using the OP-OSEM algorithm.
The reconstructed images were smoothed with a 6mm FWHM Gaussian filter,
and FDG uptake in the gut was quantified by SUV. Simultaneously, the bowel area
was imaged using T2
weighted half-Fourier acquisition single-shot turbo spin-echo (HASTE) in coronal
view. Then, breath-hold native T1 MOLLI mapping was acquired. Sequence parameters,
presented in Table 1, yielded a resolution of 1.48mmx1.48mmx7.2mm. One healthy
volunteer underwent the same MR protocol as a control to compare the T1 MOLLI
values.
Image Analysis:
From the anatomical images, small and large bowels were
manually segmented using MITK software (www.mitk.org). These contours were
superposed on the T1 MOLLI map and the PET image as shown Figure 1. SUVs above
1 were considered abnormal while those above 2 were considered “hot”. The PET
and MOLLI images were overlaid to measure the correlation between hot spots and
high T1 values.
RESULTS
PET image analysis:
Both patients presented PET activity above 1 SUV in a large
part of the organs and some hot spots, signs of bowels inflammation with PET
SUV above 2. Table 2 shows the percentage of each organ that has a PET SUV
above 1 or 2, for both patients.
T1 MOLLI analysis:
At the time of this writing, no ground truth T1 value had been
reported for the bowels, so only a comparison with the control data is
presented. Table 3 reports the mean T1 value per organ as well as the
percentage of the organ that has a high T1 (T1 above 1500 ms which corresponds
to the mean water T1 value found in healthy bowels.)
Water is normally present in the small bowels. For our
subjects it represented 7%, 31% and 27% for patient 1, patient2 and the
volunteer respectively, measured on the T2 HASTE.
PET/MOLLI comparison:
Hot spots and high T1 regions overlay in 1% of the bowels
for patient 1 and 7% for patient 2, not necessarily within the water areas of
the bowels. An example is shown Figure 1 where yellow arrows point to hot spots
that correlate with high T1 values, where no water is visible on the anatomy
image.
CONCLUSIONS
Our
preliminary results suggest that GIT inflammation was identified by high SUV on
FDG-PET. Both patients with GIT symptoms showed increased uptake over most of
their GIT and hot spots in approximately 2-8% of their GIT. Bowel inflammation is
not common in healthy subjects [3], so our results suggest that this may be
related to SSc. Only some hot spots (1-7%) correspond to high T1 values which
could be due to edema caused by the inflammation. Better evaluation of the
water content will be added in future studies to differentiate between high T1
values due to water and high T1 values due to fibrosis. Whether hot spots would
later lead to fibrotic tissue cannot yet be confirmed. Recruitment of a larger cohort
of patients and healthy controls is required to confirm these findings in a
longitudinal study with serial scans to tract the inflammation and high T1
value areas.
Acknowledgements
This work has been partially
funded by the NMRC NUHS Centre Grant – Medical Image Analysis Core (NMRC/CG/013/2013).References
1. Gyger
G, Baron M. Gastrointestinal manifestations of scleroderma: recent progress in
evaluation, pathogenesis and management. Curr Rheumatol Rep 2012; 14:22-29.
2. Ntusi
N, Piechnik S, Francis J, et al. Subclinical myocardial inflammation and
diffuse fibrosis are common in systemic sclerosis – a clinical study using
myocardial T1-mapping and extracellular volume quantification. Journal of
Cardiovasc Magn Reson 2014; 16:21.
3. Kamel
EM, Thumshirn M, Truninger K, Schiesser M, Fried M, Padberg B, Schneiter D,
Stoeckli SJ, von Schulthess GK, Stumpe KD Significance of incidental 18F-FDG
accumulations in the gastrointestinal tract in PET/CT: correlation with
endoscopic and histopathologic results. J Nucl Med. 2004 Nov; 45(11):1804-10.